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ABSTRACT 
This study sought to identify if detectable changes in human breath profiles may be 
observed following a psychological intervention designed to induce stress; a paced 
auditory serial addition test (PASAT). 
Breath samples were collected from 22 participants (10 male and 12 female) following a 
double cross-over randomised design with 2 experimental interventions. One intervention 
required participants to listening to classical music chosen to be neutral. The other 
intervention required participants to undertake a PASAT that induced cardiovascular 
responses consistent with acute stress. Both interventions also involved two sequences 
of cognitive function tests. 
Blood-pressure and heart-rate were recorded throughout each intervention and distal 
breath samples were collected onto Tenax® TA / Carbograph 1 thermal desorption 
tubes, using an adaptive breath sampler. Samples were collected before and after the 
PASAT. Breath samples were analysed by thermal desorption gas chromatography-mass 
spectrometry. Data registration using retention indexing and peak deconvolution followed 
by partial least-squares discriminant analysis identified 6 stress sensitive compounds. A 
principal components analysis model based on these components generated a model 
with that predicted post-PASAT vs post-Neutral intervention samples with a sensitivity of 
83.3% and a selectivity of 91.6% for females, compared to 100% sensitivity and 90% 
selectivity for males.   
Of the six compounds indole, 2-hydroxy-1-phenylethanone, benzaldehyde, and 2-
ethylhexan-1-ol were identified on the basis of mass spectral, retention indexing and 
confirmation against pure standards. 2-methylpentadecane was tentatively identified 
from mass spectral and retention indexing, whilst one component has yet to be assigned, 
although the mass spectrum is indicative of a terpene. Indole and 2-methylpentadecane 
concentrations increased in response to the PASAT intervention, while the other 
compounds reduced in their abundance in human breath, possibly as a result of 
ventilation effects.  
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INTRODUCTION 
Breath profiling is innately attractive for it offers a non-invasive, safe and straightforward 
observation of multiple biochemical processes occurring within the human body. A fast 
and affordable broad-spectrum health-screen run in-clinic is a common ambition held by 
many researchers in this area. Recently the non-invasive detection of biomarkers in 
breath associated with tuberculosis (TB) [1], chronic obstructive pulmonary disease 
(COPD) [2], asthma [3] and an array of cancers [4-6] have been reported. Currently it is 
possible to isolate volatile organic compounds (VOC) from a breath sample at 
concentrations ranging from mg m-3 (ppmv) down to ng m-3 (pptv). The composition and 
concentration of the profile of VOC changes as a result of many factors not necessarily 
associated with disease; diet [7], environment [8], and exercise [9] for example. 
Psychological stress (stress) is experienced by everyone and it is a healthy response to a 
challenging or threatening environment, evoking what is known as the general 
adaptation syndrome (the fight or flight response). It is conceivable that participants 
providing breath samples for diagnostic research during a visit to a clinical facility might 
be experiencing differing degrees of stress. The UK Health and Safety Executive (HSE) 
reported over 400,000 cases of psychological stress related complaints in the UK from 
2009 to 2010 [10]. Psychological stress disorders such as anxiety and depression have 
also been shown to have a higher prevalence in patients suffering from COPD [11] and 
lung cancer compared to healthy volunteers [12]. Stress may be a common concurrent 
factor in many breath samples. 
Stress causes a cascade of hormonal releases. The most well-known is the secretion of 
cortisol, but this is only one aspect of the body’s response. Gluconeogenesis, 
glucogenolysis and lipolysis are also stimulated and increased levels of renin and 
angiotensin II enzyme are produced causing elevation in blood-pressure (BP) and heart-
rate (HR) [13]. Research into stress exposure prior to influenza vaccination has claimed 
increases in the level of antibody response in women [14]. Long-term exposure to 
psychological stress has been reported to cause headaches [15], back pain [16] and 
reduced cognitive function [17]. Such observations arouse curiosity as to whether stress 
may be identified in breath VOC profiles, and if so whether any such putative markers of 
stress might be potential confounding factors for diagnosis of disease by breath analysis. 
The observation and description of the effect of psychological stress on breath VOC, is 
currently unreported. This study, therefore, sought to engender a stress response in 
human breath using a PASAT intervention [18 and 19]. The underlying hypothesis was 
that induced stress would not be associated with identifiable changes in exhaled VOCs 
across the participant cohort. An adjunct to this study would be a tentative examination 
of any exhaled VOC compounds that appeared to be associated with a stress response in 
the event of the hypothesis being disproven. 
METHODS AND MATERIALS 
Volunteer participants. 
The study was conducted in accordance with the ethical principles of Good Clinical 
Practice and the Declaration of Helsinki. This research followed the protocols that were 
reviewed and granted a favourable opinion by the local area ethics advisory committee, 
Loughborough University; G08-P7 and G09-P5. All participants taking part in the study 
gave written informed consent. 
23 male and/or female volunteers aged between 19 and 26 years participated in the 
study, and 22 complete sets of breath samples were obtained. The study used a 
randomised cross-over design with the participants attending two sampling sessions. 
(neutral and stress), each comprising an intervention. In the neutral session, they were 
asked to sit comfortably and listen to music (neutral intervention), chosen to be non-
stressful. In the stress session they were asked to undertake a mental arithmetic test 
(PASAT intervention), chosen to elicit stress [19]. They were also asked to take a 
cognitive function assessment tests. (See Supplementary Table 1) before and after the 
intervention in both samplng sessions, See Figure 1).  
The cognitive function assessments do not induce a stress response, and were run as a 
part of another study into the effect of stress on cognitive function. The cognitive function 
study was not germane to the current study and will not be discussed further in this 
paper. 
The sampling/test sessions ran in the morning. Before the sampling/test sessions the 
participants had fasted for a minimum of 9 hr and had drunk only water during this time. 
Further, the participants had refrained from washing or using oral hygiene products on 
the morning of their visit. In each session, two VOC breath samples were collected. The 
first breath sample was taken prior to beginning the experimental interventions (neutral 
/PASAT intervention) and the second directly after completion of the intervention Figure 
1. 
Heart-rate and blood-pressure measurements 
Heart-rate (HR/bpm) and blood-pressure (BP/mmHg) were recorded using a Datex 
Ohmeda S/5 patient monitoring system. A finger clip was attached to the index finger of 
the participant’s left hand in order to monitor the HR. A Critikon 23 -33 cm Dura-Cuf® 
blood-pressure cuff was applied to the participant’s upper left arm. Following a rest 
period baseline BP and HR readings were taken at 2-minute intervals whilst the 
participant sat quietly. A further 13 readings were taken over the course of each 
experimental session at 12, 16, 19, 23, 30, 42, 45, 48, 49, 57, 60, 65 and 71 minutes. 
HR, and BP (systolic, diastolic and the mean arterial pressure) were recorded at each 
time point, see Figure 1 .  
2.2.3 Paced Auditory Serial Addition Task (PASAT)  
The PASAT, originally developed to assess the effects of neurological injury on cognition 
[18], was used to induce mental stress in a reproducible manner in participants [19]. 
Whilst remaining seated and following a 30-second practice, participants completed a 
10-minute PASAT. The PASAT required participants listen to a recording of a series of 
random single digit numbers (1 to 9) with intervals of 4.5-seconds between digit 
presentation in the first 2-minutes, decreasing by 0.5-seconds every subsequent 2-
minute period [19].. Participants were instructed add the current number to the 
previously presented number and promptly call out their response. An incorrect response 
was followed by a loud auditory error-alert to indicate a wrong answer. At pre-defined 
points over the task (approximately every 10 trials) the error-alert sounded, regardless of 
the correctness of an answer. Participants were asked to watch a live view of themselves 
during the task, displayed on a monitor in front of them. The experimenter gave prompts 
during the task if participants deviated from task instructions. Participants were told their 
performance would be recorded and displayed in a performance table.  
The neutral intervention required participants to listen to recordings of ten minutes of 
classical music comprising four instrumental pieces; Truman Sleeps composed by 
Burkhard Dallwitz, Guitar Flute & String composed by Moby, Gabriel's Oboe composed by 
Ennio Morricone and Suite Bergamasque: Clair De Lune performed by Dame Moura 
Lympany. This intervention was designed to be non-stressful. 
Breath sample collection and analysis 
Distal airway breath (4.0 dm3) was collected from participants at each sampling time in 
the test procedure (Indicated by ○B  in Figure 1). Participants donned a non-vented full 
face mask fitted with a silicone pillow (ResMed, Oxfordshire, UK), supplied with purified 
‘medair’ while they breathed in a relaxed and natural manner during the sampling 
process. Every breath was recorded with pressure sensors, and the signal from the these 
sensors was processed using analogue to digital conversion, and fed to a virtual 
instrument that controlled the sampling micro-valves that ensured a high-precision 
sampling pump (sample-flow = 1 dm3min-1) was maintained at a constant operating flow 
throughout. Digital signal processing was used to continuously analyse the breathing 
profile and control the switching signals to the micro-valves that ensured a portion of air 
from the distal airways was reproducibly sampled from each breath through an inert 
capillary onto a mixed bed sorbent trap (Tenax® TA/Carbograph 1 TD, Part No C2-AAXX-
5032 Markes International, Llantrisant, UK).  
Supplementary Figure 1 is a photograph of the breath sampling mask and 
Supplementary Figure 2 compares examples of the sampling breath profiles acquired 
from the same participant before and after the PASAT. A more complete description of 
the sampling system has been reported previously [20] and the confounding factors 
associated with the analysis of human breath by thermal desorption GC–MS especially 
those associated with the high water levels encountered in human breath samples have 
been reviewed [21]. Further a central composite design optimisation studied sample 
volumes and analyte breakthrough with multi-linear regression analysis. Breath 
sampling-flow and breath sample-volume over the ranges (0.5 to 1.4 dm3 min-1, and 2.5 
to 10 dm3 respectively) for propanone, isoprene, 2,6,6-trimethylbicyclo[3.1.1]hept-2-ene, 
butylbenzene, 4-isopropenyl-1-methylcyclohexene, phenylmethanol and 1,3-
benzothiazole were studied and a maximum sample volume of 6.2 dm3 was achievable 
without breakthrough of the most volatile components [21]. The reproducibility of this 
approach has also been evaluated and the within-subject variability was observed to be 
significantly lower than between-subject variability (p=6.23 x10-23) [22] and more 
recently this method has been used to non-invasively phenotype asthmatics [23]. 
Participants wore the breath sampling masks for 5 min to enable them to acclimatise to 
the procedure, and to develop a normal relaxed breathing pattern from which the breath 
samples were collected. The mean respiration rate across the cohort was 15 ±4 breaths 
per minute for the pre-PASAT samples and 17±3 breaths per minute post PASAT. (The 
figures in brackets indicate the 95 % confidence limit).  
 The trapped volatiles were analysed with a Varian 3800 GC interfaced to a Varian 4000 
ion-trap mass spectrometer controlled using the Saturn Workstation software package 
(Varian). Sample introduction was by two-stage thermal desorption (Markes International 
Unity Series 1 fitted with a general-purpose hydrophobic cold trap.) The instrumentation 
parameters are summarised in Table 1. The quality assurance of the analytical system 
was assessed by the analysis of a retention index standard mixture (RI STD) of 16 
components of known concentration every six breath samples. Two blanks were run 
between analytical samples to ensure the absence of any VOC carry over. Collected 
breath samples were stored at 4oC prior to analysis by TD-GC-MS. 
RESULTS AND DISCUSSION  
Blood pressure and heart rate  
Individual HR, systolic BP and diastolic BP were collated and the average observations 
show the cardiovascular responses to the PASAT and neutral interventions. Figure 1 
contrasts the changes in the observed in cardiovascular response during the PASAT 
(labelled P) and the neutral sessions .  
PASAT Response Score. 
The participants’ individual cardiovascular responses to the PASAT and neutral 
interventions were scored on the basis of observed changes in their systolic blood 
pressure and heart rate. The average of the 3 initial baseline observations were used to 
give BP and HR start values ( PstartS and HRstart ). The maximum observed value of the 4 
readings taken during the intervention periods ( PSmax and HRmax ) were assigned the 
points of maximum “stress”. Equation1 defines a PASAT response score (PSR) derived 
for the PASAT (PSRS) and neutral interventions (PSRN).  
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The PSR sought to emphasise the relative change in systolic blood pressure that 
occurred during the intervention (∆ ௌܲሻ compared to baseline observationsሺ ௌܲௌ௧௔௥௧ሻ. Heart 
rate was also included in the same manner providing a ratio between the overall change 
(∆ܪܴ) and the baseline values. The PSR score in Equation 1 was framed to give higher 
score for those individuals showing the largest cardiovascular responses under the 
interventions. The PSR scores for the participants are summarised in Table 2 and the 
box-whisker plot in Figure 1 contrasts the responses for the male and female 
participants. One male participant did not exhibit a stress response (PSRS = 0.9, PSRN 
=5.3). The average responses for the remaining 21 participants was a PSRS of 64.5 ± 24 
compared to PSRN score of 4.5 ± 2) The median PSR score during the neutral 
intervention was 3.5 compared to 428 for the PASAT intervention. Male and female 
responses were not statistically different with Female PSR scores showed a greater 
range of responses during the PASAT intervention (PSR = 12 to 233), while it was the 
male participants who had the greatest variability (PSR = 0.1 to 18.6) in the neutral 
state. Overall, the cardiovascular responses summarised in Figure 1 and by the PSR 
scores are consistent with the participants experiencing psychological stress from the 
PASAT intervention. 
Chromatographic data   
The gas chromatographic-mass spectrometric (GC-MS) data were processed following a 
work-flow that has been described previously [21]. Retention times were correlated to a 
retention index scale constructed from a primary retention ladder generated from a 
quality assurance standard for the analysis, and a secondary retention index scale based 
on the retention times of 5 ubiquitous siloxane components present in all breath 
samples as a result of hydrolysis of the active phases within the analytical system. Figure 
2 illustrates a typical example of the total ion current (TIC) chromatograms with both 
retention time and retention index values (RIU) obtained from the blanks and breath 
samples collected under the two experimental sessions.  
The GC-MS data were deconvolved using AnalyzerPro (Spectral Works, UK), and a typical 
breath sample would yield between 300 and 400 individual components. A breath matrix 
was constructed that contained 154 breath VOC that were unique to breath and not 
found in any background sample. Each component in the breath matrix was assigned a 
unique reference number that began with the prefix BRI – followed by the retention index 
value for that component. The final 5 numbers in the reference were the 5 most 
abundant ions in the components de-convolved spectrum. So for example the compound 
indol has a retention index of 1286 and the five most abundant peaks in decreasing 
order are m/z 117, m/z 90, m/z 89, m/z 63 and m/z 73, so the reference for indole was 
BRI1286-117-90-89-63-73. Saturn MS workstation software (Varian inc, UK) was used to 
integrate peak areas for each breath component’s extracted ion chromatograms (XIC). 
Compounds that were present in less than 30% of the breath samples collected were 
also excluded from the data modelling, and this left 50 breath components that were 
used in the resultant multi-variate analysis (MVA) [24,25].  
Multi-variate analysis 
The breath matrix consisted of the peak areas of the 50 VOC breath components 
(variables) against the participants (observations). MVA was conducted using SIMCA-P + 
software (Version 12, Umetrics, UK). Partial least squared discriminate analysis (PLS-DA) 
was initially performed on the post intervention samples from both PASAT and neutral 
experimental sessions. All variables were assigned to a single block and a weighting of 
1/√ܤ݈݋ܿ݇ was applied making the total variance of all variables equal to 1. In addition 
Pareto Variance (ParN) was selected for base scaling of the data set; this scaling method 
takes each variable, subtracts it from the mean of that variable set and divides it by the 
square root of the standard deviation for the variable set [26,27]. The S-plot generated 
from this statistical model (Figure 3) indicated six possible VOC variables (α1 to α6) that 
changed in response to interventions experienced by the participants. Principle 
component analysis (PCA) of these six VOC variables enabled the separation between the 
PASAT and neutral observations to be evaluated. The score plots generated from these 
data are given in Figure 4. In each plot responses from the PASAT and neutral 
interventions are seen to cluster and a distinction between breath profiles obtained 
under the two experimental sessions can be observed. The principle components 
identified, exhibited 44.1% [PC1] and 15.7% [PC2] of the total explained variance of the 
data set for male participants yielding a 100% sensitivity (% of correctly assigned true 
positive observations) for the male PASAT observations and 90% selectivity (% of 
correctly assigned true negative observation) for the neutral observations. In contrast to 
this the female observations produced a weaker model and yielded a sensitivity of 83.3% 
and a selectivity of 91.6%. The total variance modelled by each component was 34.5% 
and 28.4% for [PC1] and [PC2] respectively. Further when the multivariate results were 
cross-correlated to the PSR scores the outliers were found to have anomalous PSR 
scores. Participants 4 and 18 had low PSR scored during the PASAT intervention and 
Participant 6 scored a higher PSR score in the neutral intervention than the PASAT 
intervention (Table 2).  
Preliminary identification of PASAT sensitive breath components. 
Elucidation of the VOC components α1 to α6 was based on three tests. The first was a 
“satisfactory” match of the de-convoluted spectrum generated from Analyzer pro to the 
respective entry in the NIST MS library (NIST05). “Satisfactory” defined in this instance 
as forward (direct matching of spectrum peaks to library reference spectrum) and 
reverse (matching by omitting spectrum peak not present in the library spectrum) match 
factor with a value greater than, or equal to, 650, see Table 3 [28].  
The second test was a “satisfactory” match between the observed retention index value 
(IU) and the estimated retention index value obtained from NIST05 MS library. 
“Satisfactory” was defined as a difference not greater than ±50 IU. The recorded 
retention index value for α2, see Table 3, of 1063 IU for BRI1063-105-77-52-106-51 
(indicated by mass spectrometric library matching to be 2-Hydroxy-1-phenylethanone) did 
not match the estimated NIST retention index value of 1272 IU. No record of an 
experimental retention index for this compound for a DB5 (5% phenyl 95 % methyl) 
stationary phase appears to be currently available.  
The third and final test was based on a matching the preliminary assignments in Table 3 
to standards analysed under the same conditions, Table 1. An adsorbent sampling tube 
was spiked with 0.1 µl of a 50 µg ml-1 methanol solution of: indole (α1), 2-hydroxy-1-
phenylethanone (α2), 1,4-Cyclohexadiene, 1-methyl-4-(1-methylethyl) (α4), benzaldehyde 
(α5), 2-ethylhexan-1-ol (α6); all reagents were purchased from Aldrich. The an on-column 
masses of each of the components were 500 pg. 2-methylpentadecane (α3) was not 
available commercially and was not included in this test.  
These three tests confirmed the assignments of indole, 2-hydroxy-1-phenylethanone, 
benzaldehyde, and 2-ethylhexan-1-ol. α4 was not confirmed as 1,4-Cyclohexadiene, 1-
methyl-4-(1-methylethyl) however, the mass spectrum indicates that α4 was likely to be a 
terpene. 2-methylpentadecane (α3) remains a tentative assignment and Table 3 
summarises the PASAT sensitive components. 
The origins of these VOC in breath are not well defined and may be generated through a 
combination of independent mechanisms. Indeed it is perhaps to soon postulate 
biological origins and roles for these VOC’s as part of a stress-sensitive response in 
breath. At this stage it is helpful to note that benzaldehyde is a common food component 
and occurs naturally in fruits like apples and honey [31,30] likewise terpenes occur 
naturally in foodstuffs, [29]. These components may be due to dietary intake and may 
not have an endogenous origin. Indole is associated with the production of the essential 
amino acid tryptophan, which in turn is part of the pathway that produces serotonin; 
previously reported to be involved in cardiovascular and psychological response to acute 
stress [32]. Indole may also be generated from tryptophan metabolism by indole positive 
bacteria in the gastro intestinal system. 2-Ethylhexan-1-ol has been associated with poly 
vinyl chloride (PVC) [33] and also as a potential VOC marker of lung cancer [34]. In 
addition 2-ethylhexan-1-ol has also been observed in the headspace of in-vitro cultures 
of lung carcinoma A549 cells [35]. Methylated hydrocarbons have been reported as the 
endogenous products of oxidative stress and numerous VOCS in this class have been 
identified as potential biomarkers of various cancers [6, 33].  
Example responses from Participant (14, Table 2) for these six compounds are presented 
in Figure 5. Indole and 2-methylpentadecane exhibit an increased or up-regulated 
response during the PASAT intervention. Across the cohort, indole signals increased from 
+140% to +360% (compared to the Neutral intervention samples) in response to the 
PASAT intervention. 2-methylpentadecane increased to a lesser extent, between +30% to 
+80% increases compared to the Neutral intervention. The remaining four components 
show a reduced or down-regulated response compared to the Neutral Intervention.  
The collective scores for the six VOC markers were combined by taking their euclidian 
distance, based on the peak intensities (ܫோ) to generate a marker score (CMS), see 
Equation 2 and the box whisker plots in Figure 6. The median CMS for the neutral 
intervention was 5.42x104 compared to 4.62x104 for the PASAT intervention. Female 
participants exhibited the greatest range and variability during the PASAT intervention. In 
contrast male participants showed the widest range and variability during the neutral 
intervention. In comparison to the PSR (Figure 1) the CMS results show equivalent trends 
in the female participants with an increase in range and variability in breath samples 
collected under PASAT intervention when compared to the results from the neutral 
intervention. This correlation was not reflected in the male participants, one reason for 
this maybe due to the lower intensities observed for the down regulated breath 
components; indicating a higher rate of clearance.       
 
ܥܯܵ ൌ ඩ෍ ܫோଶ			
଺
ఈୀଵ
                          (2) 
SUMMARY 
The PASAT intervention was used to induce cardiovascular reactions indicative of acute 
psychological stress in the participants. Our starting hypothesis that no change in the 
VOC profile would occur was not proven and these preliminary findings are consistent 
with the possible existence of a stress-related response in the VOC profiles of humans. 
Four of the six most PASAT responsive VOCs have been identified through combined 
mass spectral, retention index and chemical standard matches. A combination of all six 
of these PASAT responsive components, enabled the population to be classified as 
PASAT responsive or Neutral with a sensitivity of 83.3% and a selectivity of 91.6% for 
females, compared to 100% sensitivity and 90% selectivity for males. Further the 
individuals who were not correctly classified though these six VOC were either observed 
to exhibit stress, during their neutral visits (induced we think by the unfamiliar 
surroundings of the test rooms and laboratory environments), or who had low PSR 
scores; indicative of not experiencing stress during the PASAT intervention. 
It seems to reasonable to take as a starting preposition that stressed people breath 
faster, with increased pulse rates and elevated blood-pressure, and this is likely to 
change their VOC profile; indeed the four down-regulated VOCs may have been depleted 
through increased ventilation from elevated heart-rate, and respiratory rate during the 
PASAT. If stress induced enhanced ventilation causes a reduction in levels of markers, or 
perturbs patterns of markers then additional controls in breath sampling protocols may 
need to be developed. In contrast 2-methyl,pentadecane and indole, which were 
observed to be up–regulated in this study need to be verified in larger studies before any 
indication could be derived that they were indicative of a metabolic/biochemical 
response to the PASAT intervention and by inference stress.  
The retrospective quantitation of the six VOC was not possible, however the levels are 
low, approaching the limit of what is feasible to analyse in a clinical setting. If the 
sampling and transfer efficiencies were similar to those obtained during the verification 
with standards then the concentrations involved would lie across an estimated that 
would be unlikely to be greater than 20 ng m-3 for indole, and 4.8 µg m-3 for 
benzaldehyde, for example. Targeted studies with labelled standards with a larger 
participant cohort would be a logical follow up to this study. 
Demonstrations of the utility of breath analysis in providing next generation in-community 
diagnostic capability through monitoring biochemical changes in the human body 
continue to be reported [1]. This study indicates that the human VOC profile may also be 
sensitive to non-physical stimuli. Physical disease may not be the only contributing factor 
in breath profiling and the acquisition of samples and data from people undergoing 
traumatic and emotionally challenging diagnoses associated with serious diseases may 
need to consider this factor.  
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Figure 1. Left. Mean responses of 22 participants for systolic blood pressure (PS, top), and heart rate (HR, bottom) over the 70 min stress (solid line) 
and neutral (dashed line) sessions. The error bars designate the 95 % confidence limit on the mean. Right box-whisker summaries of the 
physiological stress response (PSR, see Equation 1 ) scores classified by male stressed and neutral interventions (MS and MN), female 
stressed and neutral (FS and FN) and  the total group stressed and neutral (TS and TN) results. The PRS scores the cardiovascular response 
observed at the baseline (5 min after the sampling mask was fitted) S1 and at the maximum S. The PASAT exercise is denoted by P and the 
breath samples were collected during the CFT sessions as indicated by the bracketed periods (B). 
B
0
50
100
150
200
250
MS MN FS FN TS TN
PR
S
S
CFT CFT
BS1 P
3 
 
 
Figure 2  Examples of total ion current (TIC) chromatograms of [A] filtered air, [B] neutral 
session and [C] Stressed session breath samples. Lower x- axis shows retention 
time (tR) and upper x-axis illustrates the equivalent time in retention index units 
(RIU).      
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Figure 3.  S-plot generated from the modelled covariance (P(corr)[1]) and modelled 
correlation (w[1)] of the partial least square discriminate analysis (PLS-DA) from  
the intensities (peak areas) of 50 breath components (variables) from 44 breath 
samples (observations). The six variables highlighted (black dots) were found to 
provide the highest magnitude (intensity) of the variables in the data set and 
greatest reliability (P(corr)[1] axis) of the variables in the data set; indicating 
potential putative markers sensitive to PASAT intervention.   
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Figure 4.  Unsupervised principle component analysis(PCA) of six stress sensitive breath 
components identified from PLS-DA (Figure 3) model on [A] 12 observations from 
the stressed (black dots) experimental session and 12 observations from 
neutral(open circles) experimental session from female participants. [B] 10 
observations from the stressed experimental session and 10 observations from 
the neutral experimental session from male participants.  100 % sensitivity was 
obtained for the male stressed observations and 90% selectivity was obtained for 
the neutral observations. In contrast to this the female observations yielded a 
sensitivity of 83.3% and a selectivity of 91.6% was observed. 
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Figure 5.   Overlaid extracted ion chromatograms (XIC) responses for stressed experimental 
session (dashed line) and neutral experimental session (solid line) for stress 
sensitive breath components, Indole (α1), 2-hydroxy-1-phenylethanone (α2), 2-
methylpentadecane (α3), unkonwn terpene (α4), Benzaldehyde (α5)  and 2-
ethylhexan-1-ol (α6) from a single male participant.  The intensities (IR) displayed 
have been normalised with respect to the neutral experimental session to 
indicate those components that have been up-regulated and down-regulated as a 
result of undertaking the PASAT.        
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Figure 6.  Box-whisker summaries of the combined marker scores (CMS) classified by male 
stressed and neutral interventions (MS and MN), female stressed and neutral (FS 
and FN) and the total group stressed and neutral (TS and TN) results. 
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Table 1 Instrument parameters 
Parameter Level Units 
Thermal Desorption   
Pre-purge Temperature 20 oC  
Pre-purge time 1 Min 
Pre-purge flow 18 cm3 min-1 
Tube desorption 300 oC  
Primary desorption time 5 Min 
Desorption flow 45 cm3 min-1 
Cold trap packing  general purpose 
hydrophobic 
Trapping Temperature  -10 -oC 
Trap desorption 300 oC  
Secondary desorption time 5 Min 
Trap desorption flow 2.0 cm3 min-1 
Split ratio Splitless  
Flow path temperature 180 oC 
Gas Chromatography   
Column 
DB 5 MS 60 m long x 0.25 mm id x 0.25 μm film thickness 
  
Temperature programme  
 Initial temperature 40  
 Stage 1 𝛿𝑇
𝛿𝑡
, (TStage 1), Hold time  3.3 ( 90) 0 
oC min-1(°C) min 
 Stage 2 𝛿𝑇
𝛿𝑡
, (TStage 1), Hold time 2.5 (140) 0 
oC min-1(°C) min 
 Stage 3 𝛿𝑇
𝛿𝑡
, (TStage 1), Hold time 10.0 (300) 8.9 
oC min-1(°C) min 
Total analysis time 60 Min 
Carrier gas He  
Carrier gas flow 2.0 cm3 min-1 
Ion Trap Mass Spectrometer   
Trap temperature 150 oC 
Manifold temperature 50 oC 
Transfer line temperature 300 oC 
EI scan mode EI Auto   
EI scan frequency  2 Hz 
EI scan range (m/z)40 to (m/z) 450 
Note:  Split ratio of 1:10 used for analysis of standard solution.  
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Table 2 Cardiovascular response scores of participants during the neutral (PSRN) and PASAT intervention sessions (PSRS). 
 
HRstart: Baseline heart rate recorded at start(BPM); HRmax: maximum heart-rate (BPM); 𝑃𝑆start: baseline systolic blood pressure recorded 
at start (mmHg): 𝑃𝑆max: maximum systolic blood pressure (mmHg) and PSR Pasat Response Score, see Equation 1.
Ref 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 
M/F M F M M M F F M F M M F F F M M F F F F F M 
 PASAT intervention                  
HRmax 90 119 70 92 80 77 105 91 90 90 96 100 82 134 95 84 146 66 97 95 105 85 
HRstart 78 94 54 90 69 68 81 76 66 73 59 66 72 84 75 76 88 42 82 61 65 54 
𝑃𝑆
start 141 121 112 136 121 113 105 120 129 141 113 119 102 117 107 138 112 112 116 126 110 144 
𝑃𝑆
max 152 148 122 142 144 124 125 136 155 168 129 138 117 146 121 153 152 120 133 154 132 162 
PSRS 11.6 60.6 27.5 0.9 30.3 12.9 56.7 26.1 74.2 44.8 87.6 84.5 19.7 149 34 11.1 233 40.8 27.5 125 125 72.6 
 Neutral intervention                 
HRmax 81 102 65 72 74 83 98 85 69 101 71 89 101 73 82 95 113 54 79 94 71 70 
HRstart 75 90 58 65 68 79 85 82 61 81 60 72 84 56 73 78 81 49 60 79 68 56 
𝑃𝑆
start 126 120 125 118 120 107 102 125 120 135 113 113 111 116 107 133 118 108 120 119 103 147 
𝑃𝑆
max 127 121 125 124 122 122 101 118 123 138 122 111 109 123 114 131 117 107 122 116 105 148 
PSRN 1.0 0.8 0.1 5.3 1.6 7.4 1.9 2.0 3.2 4.7 15.5 5.0 4.2 18.6 7.7 3.9 2.7 1.2 4.5 4.5 1.0 1.4 
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Table 3. Identification of PASAT sensitive breath components C1 to C6 with reverse and forward spectral match and de-convoluted spectrum 
lists.    
Ref Name and library entry Deconconvolved mass spectra MS F/R RI O/E CAS 
α1 Indole BRI-1286-117-90-89-63-73 117 (999); 90 (411); 89 (310); 63 (151); 73 (130) 850/889 1286/1276 120-72-9 
α2 2-hydroxy-1-phenylethanone BRI-1063-105-77-52-106-51 105 (999); 77 (311); 52 (172); 106 (73); 51 (66) 889/885 1063/1272 118-93-4 
#α3 2-methylpentadecane BRI-1527-41-57-43-85 
41 (999); 57 (786); 71 (776); 43 (619); 85 (412) 
 
650/658 1527/1548 1560-93-6 
*α4 unkonwn terpene compound BRI-951-93-91-92-79-121 
93 (999); 91 (435); 92 (430); 79(264);121 (217) 
 
-  951/   -      -     
α5 Benzaldehyde BRI-976-105-77-52-106-95 
105 (999); 77 (239); 52 (222); 106 (103); 95 (72 ) 
 
813/813 976/982 100-52-7 
α6 2-ethylhexan-1-ol BRI-1019-41-57-70-85-55 
41 (999); 57 (756); 70   (620); 85 (543); 55 (389) 
 
732/830 1019/995 106-76-7 
Note: MS F/R Forward (F) and reverse (R) mass spectral match of deconvolced mass spectrum to NIST05 library search.                
RI O/E Observed (O) and estimated (E) retention index value for deconvolved peak.        
# Confirmation by spectral match with NIST05 Library only as reference standard is not commercially available.    
* BRI-1527-41-57-43-85 NIST match indicates 1,4-Cyclohexadiene, 1-methyl-4-(1-methylethyl), this was not confirmed with a 
reference standard. 
 
 
 
JBR 394750 PAP Supplementary Figure 1. 
  
 Showing the sampling system in use. The participant is supplied with 
purified air at a constant flow rate (Supplementary Table 2); not visible in 
this picture. A disposable rebreathing valve prevents background air from 
contaminating the experiment. The changes in upper airway pressure are 
monitored continuously and the silicone tube connects to a pressure 
transducer; not shown. The mixed bed adsorbent trap (shown in the 
process of being fitted) is connected to the participant’s respiratory zone 
via a deactivated capillary (not visible) fitted into an adapted 
Swaglock/PTFE luerlock connector mounted on the full face respiratory 
mask. The signal from the pressure transducer is used to control the 
sampling valves and the designated part of each breath is sampled over 
many breaths. Every breath is continuously recorded along with the sample 
valve activation, see Supplementary Figure 2. 
 
 
 
JBR 394750 PAP Supplementary Figure 2.  
 A close up of part of the breath sampling sequence (top), and the whole 
sampling sequence (bottom) taken from the same participant following a 
PASAT intervention top trace, and neutral session bottom trace. The 
changes in respiration profiles and variability are evident for this 
participant. 
Blue trace is the pressure trace, Red is the sample valve control signal, 
high = sample. 
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JBR 394750 PAP Supplementary Table 1. Cognitive function tests 
 
During each of the two visits the participants also under took a four cognitive function tests before and 
after the intervention period. The tests were a Stroop test, a Flanker test, a Sternberg paradigm, and a 
Rapid Visual Information Processing Test (RVIP). Each test lasted approximately 5 minutes and they were 
always given in the same order. In brief, the Stroop test, involved presenting the participants with words for 
a colour eg blue, red, green etc. The text colour for these words was different to the written colour 
presented. The aim was to discern the written colour and not the colour it was presented in. The Flanker 
task required the participant to view an image of three arrows in a line, each pointing randomly left or right. 
The aim was identify correctly the direction of the centre arrow while ignoring the flanking arrows. The 
Sternberg test is a memory test and a measure of working memory. Finally, the RVIP test presented the 
participants with a series of random numbers from 1 to 9 and required the participant to indicate when 
they observed three consecutive odd numbers. This battery of  tests were prepared at the School of Sport, 
Exercise and Health Science at Loughborough University 
 
JBR 394750 PAP  Supplementary Table 2  Breath Sampling parameters 
Parameter Level Units 
Sampling tube, 3.5 “stainless steel standard thermal desorption tube. 
Mass of Tenax 150 mg 
Mass of Carbograph 1TD 200 mg 
Breath sample flow 1.0 dm3 min-1 
Breath sample volume 4.0 dm3 
Indicative numbers of separate breaths sampled+ 95% confidence limit 185 + 57  
Filtered Air  sample flow 2.0 dm3 min-1 
Filtered Air sample volume 4.0 dm3 
 
